MXPA02012409A - Derivados de pirrol para tratamiento del sida. - Google Patents
Derivados de pirrol para tratamiento del sida.Info
- Publication number
- MXPA02012409A MXPA02012409A MXPA02012409A MXPA02012409A MXPA02012409A MX PA02012409 A MXPA02012409 A MX PA02012409A MX PA02012409 A MXPA02012409 A MX PA02012409A MX PA02012409 A MXPA02012409 A MX PA02012409A MX PA02012409 A MXPA02012409 A MX PA02012409A
- Authority
- MX
- Mexico
- Prior art keywords
- alkyl
- aryl
- hydrogen
- heterocyclyl
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
La invencion se refiere a nuevos derivados de pirrol, un proceso para su fabricacion, composiciones farmaceuticas y el uso de tales compuestos en medicina. En particular, los compuestos de formula (I) son inhibidores del enzima transcriptasa inversa del virus de la inmunodeficiencia humana, que esta implicado en la replicacion virica. En consecuencia, los compuestos de esta invencion pueden utilizarse ventajosamente como agentes terapeuticos para el proceso mediado por el VIH. La invencion describe nuevos compuestos de formula (Ver formula I) en donde R1 es alquilo, cicloalquilo, arilo o heterociclilo; R2 es alquilo, cicloalquilo, arilo o heterociclilo; R3 es hidrogeno, alquilo, cicloalquilo, arilo o heterociclilo; R4 es hidrogeno, alquilo, carboxilo, C (=O)R, CONR' R", ciano o alquenilo, en donde R es hidrogeno, alquilo, alcoxi, trifluorometilo, metil-oxi-carbonilo o etil-oxi-carbonilo, y en donde R' y R", son de forma independiente, hidrogeno, alquilo o arilo; R5 es alquilo, arilo o un grupo -Z-C(=O)R''', en donde Z es un enlace sencillo o -CH=CH-, y en donde R''' es hidrogeno o alquilo; X representa S, S(O), S(0)2,O, N(alquilo) o X-R2 en conjunto representan CH2-arilo o CH2- heterociclilo; y con la condicion de que solamente uno de R3 y R4 es hidrogeno y el alquilo en R3 no es CF3; y esteres o eteres hidrolizables de los mismos o una sal farmaceuticamente aceptable de los mismos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0016453.3A GB0016453D0 (en) | 2000-07-04 | 2000-07-04 | Pyrrole derivatives |
PCT/EP2001/004832 WO2002002524A1 (en) | 2000-07-04 | 2001-04-30 | Pyrrole derivatives for treating aids |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02012409A true MXPA02012409A (es) | 2003-04-25 |
Family
ID=9895031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02012409A MXPA02012409A (es) | 2000-07-04 | 2001-04-30 | Derivados de pirrol para tratamiento del sida. |
Country Status (17)
Country | Link |
---|---|
US (1) | US6737429B2 (es) |
EP (1) | EP1301481A1 (es) |
JP (1) | JP2004502674A (es) |
KR (1) | KR100549884B1 (es) |
CN (1) | CN1440385A (es) |
AR (1) | AR028602A1 (es) |
AU (2) | AU2001263874B2 (es) |
BR (1) | BR0112241A (es) |
CA (1) | CA2412270A1 (es) |
EC (1) | ECSP014109A (es) |
GB (1) | GB0016453D0 (es) |
GT (1) | GT200100111A (es) |
MX (1) | MXPA02012409A (es) |
PA (1) | PA8516201A1 (es) |
PE (1) | PE20020269A1 (es) |
UY (1) | UY26720A1 (es) |
WO (1) | WO2002002524A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1405849A1 (en) * | 2002-10-04 | 2004-04-07 | Corning Incorporated | Halogenated styrene compounds and low-absorption-loss polymers obtainable therefrom |
WO2005063293A1 (ja) * | 2003-12-26 | 2005-07-14 | Masatoshi Hagiwara | Sr蛋白質のリン酸化制御方法、および、sr蛋白質の活性制御剤を有効成分とする抗ウイルス剤 |
US8048909B2 (en) | 2004-09-30 | 2011-11-01 | Takeda Pharmaceutical Company Limited | Proton pump inhibitors |
TW200628446A (en) * | 2004-12-14 | 2006-08-16 | Takeda Pharmaceuticals Co | Substituted pyrrole derivative |
US20080176919A1 (en) * | 2005-01-06 | 2008-07-24 | Pfizer Inc | Imidazole Derivatives As Enzyme Reverse Transcriptase Modulators |
ES2391757T3 (es) | 2005-08-30 | 2012-11-29 | Akeda Pharmaceutical Company Limited | Derivados de 1-H-pirrol sustituidos con 1-heterociclilsulfonilo, 2-aminometilo, 5-heteroarilo como inhibidores de la secreción de ácido |
EP2076492A4 (en) * | 2006-10-06 | 2010-12-22 | Merck Sharp & Dohme | NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS |
CA2669675A1 (en) * | 2006-11-10 | 2008-05-15 | Syndax Pharmaceuticals, Inc. | Combination of er.alpha.+ ligands and histone deacetylase inhibitors for the treatment of cancer |
US8933105B2 (en) | 2007-02-28 | 2015-01-13 | Takeda Pharmaceutical Company Limited | Pyrrole compounds |
WO2009015180A2 (en) * | 2007-07-23 | 2009-01-29 | Syndax Pharmaceuticals, Inc. | Novel compounds and methods of using them |
EP2179329A1 (en) * | 2007-10-16 | 2010-04-28 | Nikon Corporation | Illumination optical system, exposure apparatus, and device manufacturing method |
US20090131367A1 (en) * | 2007-11-19 | 2009-05-21 | The Regents Of The University Of Colorado | Combinations of HDAC Inhibitors and Proteasome Inhibitors |
JO2871B1 (en) | 2008-08-27 | 2015-03-15 | تاكيدا فارماسوتيكال كمبني ليمتد | Perol compounds |
GB0823001D0 (en) * | 2008-12-17 | 2009-01-28 | Syngenta Participations Ag | Thiophene,furan and pyrrole derivatives with plant growth regulating properties |
CN101775011B (zh) * | 2009-01-13 | 2013-07-31 | 中国人民解放军军事医学科学院毒物药物研究所 | N-取代苯基-3-甲烯杂环芳烃-2,5-二甲基吡咯类化合物及其抗hiv/aids的应用 |
AU2020388636A1 (en) * | 2019-11-19 | 2022-05-26 | New York Blood Center, Inc. | Substituted heterocyclics with therapeutic activity in HIV |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3644631A (en) * | 1969-05-13 | 1972-02-22 | Endo Lab | Therapeutic methods utilizing aryl pyrrol-3-yl ketones |
US4282242A (en) * | 1980-03-07 | 1981-08-04 | Pfizer Inc. | Antidiabetic pyrrolecarboxylic acids |
US4347186A (en) * | 1980-10-20 | 1982-08-31 | Syntex (U.S.A.) Inc. | Process for preparing 5-aroyl 1,2-dihydro-3-H pyrrolo[1,2-a]pyrrole-1-carboxylic acids and novel intermediates therein |
ES2139676T3 (es) * | 1992-12-17 | 2000-02-16 | Pfizer | Pirazoles sustituidos como antagonistas del crf. |
EP0764153A1 (en) * | 1994-06-06 | 1997-03-26 | Pfizer Inc. | Substituted pyrazoles having corticotropin-releasing factor (crf) antagonist activity |
TW406075B (en) * | 1994-12-13 | 2000-09-21 | Upjohn Co | Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds |
CA2260213C (en) * | 1996-07-11 | 2005-03-29 | Pfizer Inc. | Pyridylpyrrole compounds useful as interleukin- and tnf antagonists |
DE19963174A1 (de) * | 1999-12-27 | 2001-07-12 | Gruenenthal Gmbh | Substituierte Pyrrol-Mannichbasen |
-
2000
- 2000-07-04 GB GBGB0016453.3A patent/GB0016453D0/en not_active Ceased
-
2001
- 2001-04-30 KR KR1020037000138A patent/KR100549884B1/ko not_active IP Right Cessation
- 2001-04-30 WO PCT/EP2001/004832 patent/WO2002002524A1/en not_active Application Discontinuation
- 2001-04-30 AU AU2001263874A patent/AU2001263874B2/en not_active Ceased
- 2001-04-30 AU AU6387401A patent/AU6387401A/xx active Pending
- 2001-04-30 EP EP01938137A patent/EP1301481A1/en not_active Withdrawn
- 2001-04-30 CA CA002412270A patent/CA2412270A1/en not_active Abandoned
- 2001-04-30 JP JP2002507781A patent/JP2004502674A/ja active Pending
- 2001-04-30 MX MXPA02012409A patent/MXPA02012409A/es active IP Right Grant
- 2001-04-30 BR BR0112241-0A patent/BR0112241A/pt not_active Withdrawn
- 2001-04-30 CN CN01812290A patent/CN1440385A/zh active Pending
- 2001-05-04 PA PA20018516201A patent/PA8516201A1/es unknown
- 2001-05-18 UY UY26720A patent/UY26720A1/es not_active Application Discontinuation
- 2001-05-22 AR ARP010102414A patent/AR028602A1/es not_active Application Discontinuation
- 2001-05-25 PE PE2001000487A patent/PE20020269A1/es not_active Application Discontinuation
- 2001-06-12 GT GT200100111A patent/GT200100111A/es unknown
- 2001-06-13 US US09/880,534 patent/US6737429B2/en not_active Expired - Fee Related
- 2001-07-04 EC EC2001004109A patent/ECSP014109A/es unknown
Also Published As
Publication number | Publication date |
---|---|
US6737429B2 (en) | 2004-05-18 |
BR0112241A (pt) | 2003-06-24 |
AU6387401A (en) | 2002-01-14 |
CA2412270A1 (en) | 2002-01-10 |
GB0016453D0 (en) | 2000-08-23 |
EP1301481A1 (en) | 2003-04-16 |
ECSP014109A (es) | 2002-02-25 |
PE20020269A1 (es) | 2002-04-08 |
JP2004502674A (ja) | 2004-01-29 |
CN1440385A (zh) | 2003-09-03 |
KR20030014321A (ko) | 2003-02-15 |
WO2002002524A1 (en) | 2002-01-10 |
US20020032221A1 (en) | 2002-03-14 |
AU2001263874B2 (en) | 2006-10-19 |
GT200100111A (es) | 2002-03-18 |
AR028602A1 (es) | 2003-05-14 |
UY26720A1 (es) | 2001-11-30 |
PA8516201A1 (es) | 2002-07-30 |
KR100549884B1 (ko) | 2006-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA02012409A (es) | Derivados de pirrol para tratamiento del sida. | |
MY146669A (en) | Pyrazole derivatives for treating hiv | |
YU27203A (sh) | Pirazol derivati za tretiranje virusnih oboljenja | |
HUP0105077A2 (hu) | Szerin-proteáz inhibitorok és ezeket tartalmazó gyógyszerkészítmények | |
MY128463A (en) | 4' substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus | |
IL180495A (en) | Benzyl triazolone compounds as non-nucleotide reverse transcriptase inhibitors | |
DE60218511D1 (de) | Dihydroxypyrimidin-carbonsäueramid-hemmer der hiv-integrase | |
MXPA03011199A (es) | Derivados de pirazol como inhibidores de transcriptasa inversa del virus de inmunodeficiencia humana (vih). | |
DE60318874D1 (en) | Pyrazolderivate | |
WO2005000840A8 (en) | Substituted diketopiperazines and their use as oxytocin antagonists | |
HUP0203161A2 (hu) | Benzamidinszármazékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
AU2003263455A1 (en) | Pyrazole amides for treating hiv infections | |
ATE374775T1 (de) | Inhibitoren des hiv-integrase-enzyms | |
RS20080141A (en) | Inhibitors of the hiv integrase enzyme | |
AU2003264940A1 (en) | Pyrazole derivatives and their use as therapeutic agents for hiv mediated diseases | |
EA200500287A1 (ru) | Производные 4-(3, 5-дицианофенокси)пиразола для применения в качестве модуляторов обратной транскриптазы в лечении, в числе прочего, вич-инфекции | |
AP1846A (en) | Pyrazole Derivatives. | |
TNSN03088A1 (fr) | Derives de pyrazole pour le traitement d'une infection par le vih | |
WO2005028442A3 (en) | 2-pyridinone derivatives, having hiv inhibiting properties |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |